Nitric oxide scavenging by hemoglobin regulates hypoxic pulmonary vasoconstriction

Free Radical Biology and Medicine

Volumn 36, Issue 6, 2004, Pages 698-706

  Deem, Steven ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Free radicals; Hemoglobin; Hypoxic pulmonary vasoconstriction; Lung; Nitric oxide; Red blood cells

Indexed keywords

AMINO ACID DERIVATIVE; CATALASE; CYCLIC GMP; CYTOCHROME P450; GUANYLATE CYCLASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROSO DERIVATIVE; PROTEIN DERIVATIVE; PURINE DERIVATIVE; RECOMBINANT HEMOGLOBIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SCAVENGER;

CROSS LINKING; DEOXYGENATION; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME RELEASE; ERYTHROCYTE; GAS EXCHANGE; HUMAN; HYPOXIA; LUNG BLOOD FLOW; LUNG VASOCONSTRICTION; MITOCHONDRIAL RESPIRATION; MOLECULAR INTERACTION; MOLECULAR MECHANICS; NITROSATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REACTION ANALYSIS; REDUCTION KINETICS; REVIEW; STATISTICAL SIGNIFICANCE; VASCULAR SMOOTH MUSCLE;

EID: 1342306861     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2003.11.025     Document Type: Review

References (107)

1. Naeije R., Brimioulle S. Physiology in medicine: importance of hypoxic pulmonary vasoconstriction in maintaining arterial oxygenation during acute respiratory failure. Crit. Care. 5:2001;67-71.
2. Brimioulle S., LeJeune P., Naeije R. Effects of hypoxic pulmonary vasoconstriction on pulmonary gas exchange. J. Appl. Physiol. 81:1996;1535-1543.
3. Domino K.B., Chen L., Alexander C.M., Williams J.J., Marshall C., Marshall B.E. Time course and responses of sustained hypoxic pulmonary vasoconstriction in the dog. Anesthesiology. 60:1984;562-566.
4. Dorrington K.L., Clar C., Young J.D., Jonas M., Tansley J.G., Robbins P.A. Time course of the human pulmonary vascular response to 8 hours of isocapnic hypoxia. Am. J. Physiol. 273:1997;H1126-H1134.
5. Peake M.D., Harabin A.L., Brennan N.J., Sylvester J.T. Steady-state vascular responses to graded hypoxia in isolated lungs of five species. J. Appl. Physiol.: Respir. Environ. Exercise Physiol. 51:1981;1214-1219.
6. Vejlstrup N.G., Dorrington K.L. Intense slow hypoxic pulmonary vasoconstriction in gas-filled and liquid-filled lungs: an in vivo study in the rabbit. Acta Physiol. Scand. 148:1993;305-313.
7. Madden J.A., Vadula M.S., Kurup V.P. Effects of hypoxia and other vasoactive agents on pulmonary and cerebral artery smooth muscle cells. Am. J. Physiol. 263:1992;L384-L393.
8. Murray T.R., Chen L., Marshall B.E., Macarak E.J. Hypoxic contraction of cultured pulmonary vascular smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 3:1990;457-465.
9. Weissmann N., Grimminger F., Olschewski A., Seeger W. Hypoxic pulmonary vasoconstriction: a multifactorial response? Am. J. Physiol. Lung Cell. Mol. Physiol. 281:2001;L314-L317.
10. Voelkel N.F. Mechanisms of hypoxic pulmonary vasoconstriction. Am. Rev. Respir. Dis. 133:1986;1186-1195.
11. Shirai M., Shimouchi A., Kawaguchi A.T., Sunagawa K., Ninomiya I. Inhaled nitric oxide: diameter response patterns in feline small pulmonary arteries and veins. Am. J. Physiol. 270:1996;H974-H980.
12. Hillier S.C., Graham J.A., Hanger C.C., Godbey P.S., Glenny R.W., Wagner W.W. Jr. Hypoxic vasoconstriction in pulmonary arterioles and venules. J. Appl. Physiol. 82:1997;1084-1090.
13. Staub N.C. Site of hypoxic pulmonary vasoconstriction. Chest. 88:1985;240S-245S.
14. 2 sensor in rat pulmonary vasculature. Circ. Res. 73:1993;1100-1112.
15. Barman S.A. Potassium channels modulate hypoxic pulmonary vasoconstriction. Am. J. Physiol. 275:1998;L64-L70.
16. 2+ release from intracellular stores is an initial step in hypoxic pulmonary vasoconstriction of rat pulmonary artery resistance vessels. Circulation. 96:1997;3647-3654.
17. Post J.M., Hume J.R., Archer S.L., Weir E.K. Direct role for potassium channel inhibition in hypoxic pulmonary vasoconstriction. Am. J. Physiol. 262:1992;C882-C890.
18. 2+ in pulmonary and cerebral arterial myocytes. Am. J. Physiol. 265:1993;L591-L597.
19. Yuan X.J., Tod M.L., Rubin L.J., Blaustein M.P. Contrasting effects of hypoxia on tension in rat pulmonary and mesenteric arteries. Am. J. Physiol. 259:1990;H281-H289.
20. 2+]i and contraction: responses to diphenyleneiodonium and hypoxia. Am. J. Physiol. 273:1997;L603-L611.
21. Ward J.P.T., Aaronson P.I. Mechanisms of hypoxic pulmonary vasoconstriction: can anyone be right? Respir. Physiol. 115:1999;261-271.
22. Archer S., Michelakis E. The mechanism(s) of hypoxic pulmonary vasoconstriction: potassium channels, redox O(2) sensors, and controversies. News Physiol. Sci. 17:2002;131-137.
23. 2-sensitive potassium channels in the pulmonary circulation. Adv. Exp. Med. Biol. 475:2000;219-240.
24. Michelakis E.D., Hampl V., Nsair A., Wu X., Harry G., Haromy A., Gurtu R., Archer S.L. Diversity in mitochondrial function explains differences in vascular oxygen sensing. Circ. Res. 90:2002;1307-1315.
25. Waypa G.B., Schumacker P.T. O(2) sensing in hypoxic pulmonary vasoconstriction: the mitochondrial door re-opens. Respir. Physiol. Neurobiol. 132:2002;81-91.
26. Waypa G.B., Chandel N.S., Schumacker P.T. Model for hypoxic pulmonary vasoconstriction involving mitochondrial oxygen sensing. Circ. Res. 88:2001;1259-1266.
27. Chandel N.S., Schumacker P.T. Cellular oxygen sensing by mitochondria: old questions, new insight. J. Appl. Physiol. 88:2000;1880-1889.
28. 2 mechanisms of guanylate cyclase activation in oxygen-dependent responses of rat pulmonary circulation. Am. J. Physiol. 268:1995;L546-L550.
29. 2-elicited responses. Am. J. Physiol. 269:1995;L637-L644.
30. Weissmann N., Grimminger F., Voswinckel R., Conzen J., Seeger W. Nitro blue tetrazolium inhibits but does not mimic hypoxic vasoconstriction in isolated rabbit lungs. Am. J. Physiol. 274:1998;L721-L727.
31. Weissmann N., Tadic A., Hanze J., Rose F., Winterhalder S., Nollen M., Schermuly R.T., Ghofrani H.A., Seeger W., Grimminger F. Hypoxic vasoconstriction in intact lungs: a role for NADPH oxidase-derived H(2)O(2)? Am. J. Physiol. Lung Cell. Mol. Physiol. 279:2000;L683-L690.
32. Marshall C., Mamary A.J., Verhoeven A.J., Marshall B.E. Pulmonary artery NADPH-oxidase is activated in hypoxic pulmonary vasoconstriction. Am. J. Respir. Cell Mol. Biol. 15:1996;633-644.
33. Weissmann N., Voswinckel R., Hardebusch T., Rosseau S., Ghofrani H.A., Schermuly R., Seeger W., Grimminger F. Evidence for a role of protein kinase C in hypoxic pulmonary vasoconstriction. Am. J. Physiol. 276:1999;L90-L95.
34. Zhu D., Birks E.K., Dawson C.A., Patel M., Falck J.R., Presberg K., Roman R.J., Jacobs E.R. Hypoxic pulmonary vasoconstriction is modified by P-450 metabolites. Am. J. Physiol. Heart Circ. Physiol. 279:2000;H1526-H1533.
35. + currents in pulmonary arterial myocytes. Am. J. Physiol. 268:1995;C259-C270.
36. Dipp M., Nye P.C., Evans A.M. Hypoxic release of calcium from the sarcoplasmic reticulum of pulmonary artery smooth muscle. Am. J. Physiol. Lung Cell. Mol. Physiol. 281:2001;L318-L325.
37. Ward J.P.T., Robertson T.P. The role of the endothelium in hypoxic pulmonary vasoconstriction. Exp. Physiol. 80:1995;793-801.
38. Deem S., Swenson E.R., Alberts M.K., Hedges R.G., Bishop M.J. Red-blood-cell augmentation of hypoxic pulmonary vasoconstriction: hematocrit dependence and the importance of nitric oxide. Am. J. Respir. Crit. Care Med. 157:1998;1181-1186.
39. Hasunuma K., Yamaguchi T., Rodman D.M., O'Brien R.F., McMurtry I.F. Effects of inhibitors of EDRF and EDHF on vasoreactivity of perfused rat lungs. Am. J. Physiol. 260:1991;L97-L104.
40. Liu S., Crawley D.E., Barnes P.J., Evans T.W. Endothelium-derived relaxing factor inhibits hypoxic pulmonary vasoconstriction in rats. Am. Rev. Respir. Dis. 143:1991;32-37.
41. Persson M.G., Gustafsson L.E., Wiklund N.P., Moncada S., Hedquist P. Endogenous nitric oxide as a probable modulator of pulmonary circulation and hypoxic pressor response in vivo. Acta Physiol. Scand. 140:1990;449-457.
42. Brashers V.L., Peach M.J., Edward C.R. Jr. Augmentation of hypoxic pulmonary vasoconstriction in the isolated perfused rat lung by in vitro antagonists of endothelium-dependent relaxation. J. Clin. Invest. 82:1988;1495-1502.
43. Archer S.L., Tolins J.P., Raij L., Weir E.K. Hypoxic pulmonary vasoconstriction is enhanced by inhibition of the synthesis of an endothelium derived relaxing factor. Biochem. Biophys. Res. Commun. 164:1989;1198-1205.
44. Shirai M., Shimouchi A., Kawaguchi A.T., Ikeda S., Sunagawa K., Ninomiya I. Endogenous nitric oxide attenuates hypoxic vasoconstriction of small pulmonary arteries and veins in anaesthetized cats. Acta Physiol. Scand. 159:1997;263-264.
45. Sprague R.S., Thiemermann C., Vane J.R. Endogenous endothelium-derived relaxing factor opposes hypoxic pulmonary vasoconstriction and supports blood flow to hypoxic alveoli in anesthetized rabbits. Proc. Natl. Acad. Sci. USA. 89:1992;8711-8715.
46. Sander M., Welling K.-L.K., Ravn J.B., Boberg B., Amtorp O. Endogenous NO does not regulate baseline pulmonary pressure, but reduces acute pulmonary hypertension in dogs. Acta Physiol. Scand. 178:2003;269-277.
47. Blitzer M.L., Loh E., Roddy M.-A., Stamler J.S., Creager M.A. Endothelium-derived nitric oxide regulates systemic and pulmonary vascular resistance during acute hypoxia in humans. J. Am. Coll. Cardiol. 28:1996;591-596.
48. Fagan K.A., Fouty B.W., Tyler R.C., Morris K.G. Jr., Hepler L.K., Sato K., LeCras T.D., Abman S.H., Weinberger H.D., Huang P.L., McMurtry I.F., Rodman D.M. The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresponsive to mild hypoxia. J. Clin. Invest. 103:1999;291-299.
49. Pison U., Lopez F.A., Heidelmeyer C.F., Rossaint R., Falke K.J. Inhaled nitric oxide reverses hypoxic pulmonary vasoconstriction without impairing gas exchange. J. Appl. Physiol. 74:1993;1287-1292.
50. Frostell C.G., Blomqvist H., Hedenstierna G., Lundberg J., Zapol W.M. Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology. 78:1993;427-435.
51. Rengasamy A., Johns R.A. Determination of Km for oxygen of nitric oxide synthase isoforms. J. Pharmacol. Exp. Ther. 276:1996;30-33.
52. Dweik R.A., Laskowski D., Abu-Soud H.M., Kaneko F., Hutte R., Stuehr D.J., Erzurum S.C. Nitric oxide synthesis in the lung. Regulation by oxygen through a kinetic mechanism. J. Clin. Invest. 101:1998;660-666.
53. Kantrow S.P., Huang Y.C., Whorton A.R., Grayck E.N., Knight J.M., Millington D.S., Piantadosi C.A. Hypoxia inhibits nitric oxide synthesis in isolated rabbit lung. Am. J. Physiol. 272:1997;L1167-L1173.
54. Ide H., Nakano H., Ogasa T., Osanai S., Kikuchi K., Iwamoto J. Regulation of pulmonary circulation by alveolar oxygen tension via airway nitric oxide. J. Appl. Physiol. 87:1999;1629-1636.
55. Vaughan D.J., Brogan T.V., Kerr M.E., Deem S., Luchtel D.L., Swenson E.R. Contributions of nitric oxide synthase isozymes to exhaled nitric oxide and hypoxic pulmonary vasoconstriction in rabbit lungs. Am. J. Physiol. Lung Cell. Mol. Physiol. 284:2003;L834-L843.
56. Weissmann N., Grimminger F., Walmrath D., Seeger W. Hypoxic vasoconstriction in buffer-perfused rabbit lungs. Respir. Physiol. 100:1995;159-169.
57. Duke H., Killick E. Pulmonary vasomotor responses of isolated perfused cat lungs to anoxia. J. Physiol. 117:1952;303-316.
58. Hauge A. Conditions governing the pressor response to ventilation hypoxia in isolated perfused rat lungs. Acta Physiol. Scand. 72:1968;33-44.
59. McMurtry I.F., Hookway B.W., Roos S.D. Red blood cells but not platelets prolong vascular reactivity of isolated rat lungs. Am. J. Physiol. 234:1978;H186-H191.
60. Hakim T.S., Malik A.B. Hypoxic vasoconstriction in blood and plasma perfused lungs. Respir. Physiol. 72:1988;109-121.
61. Hakim T.S., Macek A.S. Role of erythrocyte deformability in the acute hypoxic pressor response in the pulmonary vasculature. Respir. Physiol. 72:1988;95-107.
62. Hakim T.S., Macek A.S. Effect of hypoxia on erythrocyte deformability in different species. Biorheology. 25:1988;857-868.
63. Carlin R.E., Ferrario L., Boyd J.T., Camporesi E.M., McGraw D.J., Hakim T.S. Determinants of nitric oxide in exhaled gas in the isolated rabbit lung. Am. J. Respir. Crit. Care Med. 155:1997;922-927.
64. Grimminger F., Spriestersbach R., Weissmann N., Walmrath D., Seeger W. Nitric oxide generation and hypoxic vasoconstriction in buffer-perfused rabbit lungs. J. Appl. Physiol. 78:1995;1509-1515.
65. Berg J.T., Deem S., Kerr M.E., Swenson E.R. Hemoglobin and red blood cells alter the response of expired nitric oxide to mechanical forces. Am. J. Physiol. Heart Circ. Physiol. 279:2000;H2947-H2953.
66. Kao S.J., Wei J., Hwang C.P., Lieu M.W., Jiang J.S., Wang D., Chen H.I. Modulatory effect of blood cells on hypoxic vasoconstriction response and nitric oxide release in rat lungs. J. Formosan Med. Assoc. 98:1999;39-44.
67. Mazmanian G.-M., Baudet B., Brink C., Cerrina J., Kirkiacharian S., Weiss M. Methylene blue potentiates vascular reactivity in isolated rat lungs. J. Appl. Physiol. 66:1989;1040-1045.
68. Heller A., Ragaller M., Schmeck J., Fluth H., Muller M., Albrecht D.M., Koch T. Role of NO and endothelin in hemoglobin-induced pulmonary vasoconstriction. Shock. 10:1998;401-406.
69. Deem S., Berg J.T., Kerr M.E., Swenson E.R. Effects of the RBC membrane and increased perfusate viscosity on hypoxic pulmonary vasoconstriction. J. Appl. Physiol. 88:2000;1520-1528.
70. Deem S., Gladwin M.T., Berg J.T., Kerr M.E., Swenson E.R. Effects of S-nitrosation of hemoglobin on hypoxic pulmonary vasoconstriction and nitric oxide flux. Am. J. Respir. Crit. Care Med. 163:2001;1164-1170.
71. Loer S.A., Peters J. Effects of haemoconcentration and haemodilution on acute hypoxia-induced pulmonary hypertension and changes in vascular compliance of isolated rabbit lungs. Intens. Care Med. 26:2000;1124-1130.
72. Deem S., Bishop M.J., Alberts M.K. Effect of anemia on intrapulmonary shunt during atelectasis in rabbits. J. Appl. Physiol. 79:1995;1951-1957.
73. Kerbaul F., Pierre S., Rondelet C., Melot C., Naeije R., Van der Linden P. Mechanisms of hemodilution induced inhibition of hypoxic pulmonary vasoconstriction. Am. J. Respir. Crit. Care Med. 167:2003;A927.
74. Defouilloy C., Teiger E., Sediame S., Andrivet P., Roudot-Thoraval F., Chouaid C., Housset B., Adnot S. Polycythemia impairs vasodilator response to acetylcholine in patients with chronic hypoxemic lung disease. Am. J. Respir. Crit. Care Med. 157:1998;1452-1460.
75. Nishiyama T., Hanaoka K. Free hemoglobin concentrations in patients receiving massive blood transfusion during emergency surgery for trauma. Can. J. Anaesth. 47:2000;881-885.
76. Reiter C.D., Wang X., Tanus-Santos J.E., Hogg N., Cannon R.O. III, Schechter A.N., Gladwin M.T. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat. Med. 8:2002;1383-1389.
77. Yamaguchi K., Asano K., Takasugi T., Mori M., Fujita H., Oyamada Y., Suzuki K., Miyata A., Aoki T., Suzuki Y. Modulation of hypoxic pulmonary vasoconstriction by antioxidant enzymes in red blood cells. Am. J. Respir. Crit. Care Med. 153:1996;211-217.
78. Catravas J.D. Removal of adenosine from the rabbit pulmonary circulation, in vivo and in vitro. Circ. Res. 54:1984;603-611.
79. Sprague R.S., Ellsworth M.L., Stephenson A.H., Lonigro A.J. ATP: the red blood cell link to NO and local control of the pulmonary circulation. Am. J. Physiol. 271:1996;H2717-H2722.
80. Ellsworth M.L., Forrester T., Ellis C.G., Dietrich H.H. The erythrocyte as a regulator of vascular tone. Am. J. Physiol. 269:1995;H2155-H2161.
81. Driessen B., Haskins S.C., Pascoe P.J., Tripp L.D., Reitan J.A. Haemodynamic effects of ATP in dogs during hypoxia-induced pulmonary hypertension. J. Vet. Pharmacol. Ther. 22:1999;213-219.
82. Lunde P.K., Waaler B.A., Walloe L. The inhibitory effect of various phenols upon ATP-induced vasoconstriction in isolated perfused rabbit lungs. Acta Physiol. Scand. 72:1968;331-337.
83. Neely C.F., Haile D.M., Cahill B.E., Kadowitz P.J. Adenosine and ATP produce vasoconstriction in the feline pulmonary vascular bed by different mechanisms. J. Pharmacol. Exp. Ther. 258:1991;753-761.
84. Davies P.F. Flow-mediated endothelial mechanotransduction. Physiol. Rev. 75:1995;519-560.
85. Barnard J.W., Wilson P.S., Moore T.M., Thompson W.J., Taylor A.E. Effect of nitric oxide and cyclooxygenase products on vascular resistance in dog and rat lungs. J. Appl. Physiol. 74:1993;2940-2948.
86. Sprague R.S., Stephenson A.H., Dimmitt R.A., Weintraub N.L., Branch C.A., McMurdo L., Lonigro A.J., Weintraub N.A. Effect of L-NAME on pressure-flow relationships in isolated rabbit lungs: role of red blood cells. Am. J. Physiol. 269:1995;H1941-H1948.
87. Uncles D.R., Daugherty M.O., Frank D.U., Roos C.M., Rich G.F. Nitric oxide modulation of pulmonary vascular resistance is red blood cell dependent in isolated rat lungs. Anesth. Analg. 83:1996;1212-1217.
88. Wilson P.S., Khimenko P., Moore T.M., Taylor A.E. Perfusate viscosity and hematocrit determine pulmonary vascular responsiveness to NO synthase inhibitors. Am. J. Physiol. 270:1996;H1757-H1765.
89. Korbut R., Gryglewski R.J. Nitric oxide from polymorphonuclear leukocytes modulates red blood cell deformability in vitro. Eur. J. Pharmacol. 234:1993;17-22.
90. Bor-Kucukatay M., Wenby R.B., Meiselman H.J., Baskurt O.K. Effects of nitric oxide on red blood cell deformability. Am. J. Physiol. Heart Circ. Physiol. 284:2003;H1577-H1584.
91. Bateman R.M., Jagger J.E., Sharpe M.D., Ellsworth M.L., Mehta S., Ellis C.G. Erythrocyte deformability is a nitric oxide-mediated factor in decreased capillary density during sepsis. Am. J. Physiol. Heart Circ. Physiol. 280:2001;H2848-H2856.
92. Doyle M.P., Galey W.R., Walker B.R. Reduced erythrocyte deformability alters pulmonary hemodynamics. J. Appl. Physiol. 67:1989;2593-2599.
93. Patel R.P., Hogg N., Spencer N.Y., Kalyanaraman B., Matalon S., Darley-Usmar V.M. Biochemical characterization of human S-nitrosohemoglobin. Effects on oxygen binding and transnitrosation. J. Biol. Chem. 274:1999;15487-15492.
94. Jia L., Bonaventura C., Bonaventura J., Stamler J.S. S- nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature. 380:1996;221-226.
95. McMahon T.J., Exton Stone A., Bonaventura J., Singel D.J., Solomon Stamler J. Functional coupling of oxygen binding and vasoactivity in S-nitrosohemoglobin. J. Biol. Chem. 275:2000;16738-16745.
96. Deem S., Kim J.U., Manjula B.N., Acharya A.S., Kerr M.E., Patel R.P., Gladwin M.T., Swenson E.R. Effects of S-nitrosation and cross-linking of hemoglobin on hypoxic pulmonary vasoconstriction in isolated rat lungs. Circ. Res. 91:2002;626-632.
97. Deem S., Eveland R., Moulding J., Kim S.S., Swenson E.R., Gladwin M.T. Pulmonary vascular effects of red blood cells containing S-nitrosohemoglobin. Am. J. Respir. Crit. Care Med. 167:2003;A828.
98. Rassaf T., Bryan N.S., Maloney R.E., Specian V., Kelm M., Kalyanaraman B., Rodriguez J., Feelisch M. NO adducts in mammalian red blood cells: too much or too little? Nat. Med. 9:2003;481-483.
99. 2/NO-linked allosteric function. J. Biol. Chem. 277:2002;27818-27828.
100. Patel R.P. Biochemical aspects of the reaction of hemoglobin and NO: implications for Hb-based blood substitutes. Free Radic. Biol. Med. 28:2000;1518-1525.
101. Lee R., Neya K., Svizzero T.A., Vlahakes G.J. Limitations of the efficacy of hemoglobin-based oxygen-carrying solutions. J. Appl. Physiol. 79:1995;236-242.
102. Bone H.G., Waurick R., Van Aken H., Jahn U.R., Booke M., Meyer J. The hemodynamic effects of cell-free hemoglobin during general and epidural anesthesia. Anesth. Analg. 89:1999;1131-1136.
103. Sefton W., Pudimat P., Bina S., Lojeski E., Mongan P., Muldoon S. Inhaled nitric oxide attenuates increased pulmonary artery pressure following diaspirin crosslinked hemoglobin (DCLHB) administration. Artif. Cells Blood Substit. Immobil. Biotechnol. 27:1999;203-213.
104. Muldoon S.M., Ledvina M.A., Hart J.L., Macdonald V.W. Hemoglobin-induced contraction of pig pulmonary veins. J. Lab. Clin. Med. 128:1996;579-584.
105. Freas W., Llave R., Jing M., Hart J., McQuillan P., Muldoon S. Contractile effects of diaspirin cross-linked hemoglobin (DCLHb) on isolated porcine blood vessels. J. Lab. Clin. Med. 125:1995;762-767.
106. Kim H.W., Greenburg A.G. Hemoglobin mediated vasoactivity in isolated vascular rings. Artif. Cells Blood Substit. Immobil. Biotechnol. 23:1995;303-309.
107. Resta T.C., Walker B.R., Eichinger M.R., Doyle M.P. Rate of NO scavenging alters effects of recombinant hemoglobin solutions on pulmonary vasoreactivity. J. Appl. Physiol. 93:2002;1327-1336.